Global Self-expandable Intracranial Stents Market Size By Type (Open Loop Stents, Closed-Loop Stents), By Application (Ischemic Stroke, Hemorrhagic Stroke), By Region, And Segment Forecasts, 2023 to 2...

The Global Self-expandable Intracranial Stents Market was valued at USD 1.3 billion in 2023 and is projected to reach USD 2.5 billion by 2031, growing at a CAGR of 8.7% during the forecast period of 2023–2031. The rising prevalence of intracranial atherosclerotic disease (ICAD) and increasing incidences of ischemic strokes are major factors driving demand for self-expandable intracranial stents. These stents are minimally invasive, highly effective in restoring cerebral blood flow, and offer an alternative to complex surgical procedures, fostering rapid market expansion.

Drivers:

1. Increasing Incidence of Neurological Disorders:

The rising global burden of strokes and cerebrovascular diseases has led to a surge in demand for minimally invasive treatments. Self-expandable intracranial stents provide a viable solution, especially in treating patients with intracranial artery stenosis.

2. Technological Advancements in Stent Design:

Innovations such as enhanced radial force, retrievability, and compatibility with advanced imaging systems are improving clinical outcomes and procedural success rates, propelling market adoption.

3. Favorable Reimbursement Policies and Clinical Guidelines:

Supportive healthcare frameworks in developed markets are facilitating the adoption of intracranial stenting procedures, improving access to advanced neurointervention therapies.

Restraints:

1. High Cost of Procedures and Devices:

The expense associated with neurovascular stenting devices and related hospital services remains a major barrier, particularly in price-sensitive markets.

2. Complications and Regulatory Challenges:

Potential complications, such as in-stent restenosis and thromboembolic events, coupled with strict regulatory pathways for approval, may impede market growth.

Opportunity:

1. Emerging Markets and Untapped Patient Populations:

Asia-Pacific and Latin America represent significant growth avenues due to the increasing number of neurology centers, improving healthcare infrastructure, and rising awareness of stroke treatment options.

2. Integration with Image-Guided Intervention Technologies:

Advanced visualization technologies integrated with stent delivery systems are enhancing procedural precision and clinical outcomes, presenting lucrative opportunities for innovation.

Market by System Type Insights:

By system type, the Balloon-expandable Self-expandable Stents segment held a dominant share in 2023 due to its proven efficacy in neurovascular interventions. However, Hybrid Self-expandable Stents are expected to gain rapid traction, offering a blend of flexibility, radial strength, and deliverability.

Market by End-use Insights:

Hospitals led the end-use segment in 2023, accounting for more than 55% of global revenue, driven by the high volume of neurointerventional procedures performed in tertiary care settings. The Ambulatory Surgical Centers (ASCs) segment is projected to witness the highest CAGR during the forecast period, attributed to shorter recovery times and cost-effective care delivery.

Market by Regional Insights:

North America held the largest share of the market in 2023 due to early adoption of advanced neurointerventional tools, robust healthcare systems, and favorable reimbursement structures. The Asia-Pacific region is poised to register the fastest growth, propelled by rising stroke incidence, healthcare reforms, and expanding medical tourism.

Competitive Scenario:

Prominent players in the Global Self-expandable Intracranial Stents Market include Medtronic plc, Stryker Corporation, MicroPort Scientific Corporation, Balt Extrusion, Terumo Corporation, and Johnson & Johnson (Cerenovus). These companies are focusing on geographic expansion, R&D investments, and product innovation.

In 2024, Stryker launched its next-generation self-expandable stent with enhanced delivery system compatibility.

In 2023, Medtronic received FDA approval for its innovative neurovascular stent platform designed for complex anatomy.

Scope of Work – Global Self-expandable Intracranial Stents Market

Report Metric Details

Market Size (2023) USD 1.3 Billion

Projected Market Size (2031) USD 2.5 Billion

CAGR (2023–2031) 8.7%

Market Segments By System Type, End-use, Region

Growth Drivers Increasing stroke cases, technology upgrades, expanding healthcare access

Opportunities Growth in emerging markets, image-guided neurointerventions

Key Market Developments:

Medtronic plc expanded its neurovascular product portfolio in 2024 with an FDA-approved self-expanding stent targeting complex intracranial stenoses.

Balt Extrusion entered a strategic alliance in 2023 to co-develop novel hybrid stent platforms aimed at improving flexibility and safety.

MicroPort Scientific Corporation initiated multi-country clinical trials in 2025 for next-gen intracranial stents incorporating bioresorbable materials.

FAQs:

1) What is the current market size of the Global Self-expandable Intracranial Stents Market?

The market was valued at USD 1.3 billion in 2023.

2) What is the major growth driver of the Global Self-expandable Intracranial Stents Market?

The primary growth driver is the increasing incidence of stroke and intracranial arterial stenosis.

3) Which is the largest region during the forecast period in the Global Self-expandable Intracranial Stents Market?

North America is projected to remain the largest regional market.

4) Which segment accounted for the largest market share in the Global Self-expandable Intracranial Stents Market?

Hospitals accounted for the largest share in 2023 due to the high volume of neurointerventional procedures.

5) Who are the key market players in the Global Self-expandable Intracranial Stents Market?

Key players include Medtronic plc, Stryker Corporation, MicroPort Scientific Corporation, Balt Extrusion, and Terumo Corporation.